American College of Cardiology
As we all work together on the front lines to best serve our patients and lead COVID-19 response planning for our institutions, the ACC is working to provide COVID-19 clinical guidance for the global cardiovascular care team.
Is Rivaroxaban Beneficial in Patients With Peripheral Artery Disease Who Had Undergone Lower-extremity Revascularization? What Are the Possible Risks of the Drug?
Login to view comments.
Click here to Login
